NCT07404332 2026-05-285-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory TumorsUniversity of IowaPhase 1 Recruiting35 enrolled
NCT02959437 2025-10-21Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)Incyte CorporationPhase 1/2 Terminated70 enrolled 14 charts